Cannabinoid receptor ligands
US7642272B2 · kind B2 · utility
46Cited by
15References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2004 |
| Grant date | Jan 5, 2010 |
| Priority date | — |
| Expiry date | Aug 29, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are disclosed compounds of the formula Ia pharmaceutically acceptable salt or solvate of the compound, which exhibit anti-inflammatory and immunomodulatory activity. Also disclosed are pharmaceutical compositions containing said compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.